Huynh Bon Huu, Nathisuwan Surakit, Tragulpiankit Pramote, Nguyen Vinh Dai, Huynh Nam Huu, Vu Thu Le Anh, Huynh Loc Thi Hong, Vo Ha Thi
Division of Clinical Pharmacy, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.
Department of Pharmacology and Clinical Pharmacy, Da Nang University of Medical Technology and Pharmacy, Da Nang, Vietnam.
J Pharm Technol. 2023 Dec;39(6):259-268. doi: 10.1177/87551225231199358. Epub 2023 Oct 5.
Clinical pharmacists' interventions (PIs) on drug-related problems (DRPs) in Vietnamese hypertensive outpatients are limited. The objective was to investigate the prevalence and nature of DRPs, and factors which are likely to have DRPs, types of PIs, and their acceptance rate in 3 Vietnamese hospitals. A prospective interventional study was conducted over a period of 3 months in 3 hospitals (from October 2021 to March 2022). Clinical pharmacists conducted medication reviews after collecting patient information from prescriptions and patient interviewing, and then identified the DRPs and suggested PIs according to the Vi-Med tool. These DRPs and PIs were reviewed by other superior clinical pharmacists and a consensus meeting with 3 cardiologists. Of 381 patients included, 344 (90.23%) experienced 1 or more DRPs. A total of 820 DRPs were identified with an average of 2.15 DRPs per patient and 415 (50.61%) were hypertension-related issues. The most common DRPs identified were "administration mode" (46.34%), "missing indication" (18.05%), "non-conformity indication" (17.80%), and "dosage" (11.95%). Comorbidity (adjusted odds ratio [AOR] = 3.985, 95% CI: 1.597-9.942, = 0.003) was the predictor of DRPs. Clinical pharmacists provided 739 PIs and 94.45% were accepted by physicians. The results of this study showed that DRPs were very common in hypertensive outpatients and highlighted the role of clinical pharmacists to identify and resolve DRPs through prompt interventions.
临床药师对越南高血压门诊患者药物相关问题(DRP)的干预有限。本研究旨在调查3家越南医院中DRP的患病率、性质、可能存在DRP的因素、干预类型及其接受率。在3家医院(从2021年10月至2022年3月)进行了为期3个月的前瞻性干预研究。临床药师在从处方收集患者信息并进行患者访谈后进行用药评估,然后根据Vi-Med工具识别DRP并提出干预措施。这些DRP和干预措施由其他上级临床药师以及与3位心脏病专家的共识会议进行审查。在纳入的381例患者中,344例(90.23%)经历了1种或多种DRP。共识别出820个DRP,平均每位患者2.15个DRP,其中415个(50.61%)为高血压相关问题。识别出的最常见DRP为“给药方式”(46.34%)、“适应证缺失”(18.05%)、“适应证不符”(17.80%)和“剂量”(11.95%)。合并症(调整优势比[AOR]=3.985,95%置信区间:1.597-9.942,P=0.003)是DRP的预测因素。临床药师提供了739项干预措施,其中94.45%被医生接受。本研究结果表明,DRP在高血压门诊患者中非常常见,并突出了临床药师通过及时干预识别和解决DRP的作用。